FFCP PHASE2:Hg19::chr18:2571528..2571568,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p1@NDC80 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_NDC80_5end |
| Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
| Association with transcript: | -10bp_to_ENST00000543946_5end |
| EntrezGene: | NDC80 |
| HGNC: | 16909 |
| UniProt: | F5H1J6 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@NDC80 |
|---|
0
20
40
60
80
100
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 8.83e-50 | 235 |
| disease of cellular proliferation | 1.10e-48 | 239 |
| organ system cancer | 2.00e-24 | 137 |
| cell type cancer | 3.06e-24 | 143 |
| hematologic cancer | 8.25e-22 | 51 |
| immune system cancer | 8.25e-22 | 51 |
| carcinoma | 1.17e-18 | 106 |
| leukemia | 4.12e-17 | 39 |
| myeloid leukemia | 8.70e-13 | 31 |
Showing 1 to 9 of 9 entries
